MetaCap

Context Therapeutics Insider Trades

NASDAQ: CNTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.16-0.0086 (-5.10%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Context Therapeutics insider activity

No Context Therapeutics insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Lehr Martin A. (Chief Executive Officer) buying 100,000 shares at $0.7008 on Jun 9, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CNTX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CNTX insider transactions

Context Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Jun 9, 2025Lehr Martin A.Chief Executive OfficerBuy100,000$70.08KForm 4
Jun 6, 2025Minai-Azary Jennifer LynnChief Financial OfficerBuy40,010$25.49KForm 4
Jun 6, 2025Levit Alex C.Chief Legal Officer, Corp. SecBuy20,000$11.52KForm 4
Feb 21, 2023Lehr Martin A.Chief Executive OfficerBuy5,823$4.90KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related